Shandong Buchang Pharmaceuticals Co (SHSE:603858) Net Issuance of Debt : ¥821 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Shandong Buchang Pharmaceuticals Co Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Shandong Buchang Pharmaceuticals Co's net issuance of debt for the three months ended in Mar. 2024 was ¥537 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Mar. 2024 was ¥821 Mil.

Shandong Buchang Pharmaceuticals Co Net Issuance of Debt Historical Data

The historical data trend for Shandong Buchang Pharmaceuticals Co's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Buchang Pharmaceuticals Co Net Issuance of Debt Chart

Shandong Buchang Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Issuance of Debt

Get a 7-Day Free Trial

475.40

641.75

38.36

-590.07

158.19

Shandong Buchang Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Issuance of Debt	Get a 7-Day Free Trial															-125.39	319.55	-116.46	80.49	537.31

Shandong Buchang Pharmaceuticals Co Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥821 Mil.

Shandong Buchang Pharmaceuticals Co Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Shandong Buchang Pharmaceuticals Co's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Buchang Pharmaceuticals Co Ltd (SHSE:603858) » Definitions » Net Issuance of Debt

Traded in Other Exchanges

N/A

Address

No. 369, Zhonghua West Road, Shandong Province, Heze, CHN, 274000

Website

http://www.buchang.com

Shandong Buchang Pharmaceuticals Co Ltd is a pharmaceuticals company engaged in drug manufacturing. It specializes in the research and development, production and sale of Traditional Chinese patent medicines, supplemented by fields such as hi-tech industry and health industry. The company offers drugs for cardiac and cerebral vascular disease, diabetes, urinary and digestive disease, respiratory disease, gynecological disease and others. Geographically, the company holds its production bases in Shandong, Shaanxi, Hebei and Northeast China, with its marketing network spreading all over the major provinces of China.

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Headlines

No Headlines